Following IL-21R–Fc intervention, the frequency of plasmablasts and AQP4-ab levels were significantly reduced, corroborating previous studies in NMOSD and myasthenia gravis (7, 15, 30). The gene discussed is IL21R; the disease is myasthenia gravis.